Date Filed | Type | Description |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2023 |
4
| Fischer David B (Director) has filed a Form 4 on BALCHEM CORP
Txns:
| Sold 3,000 shares
@ $127.007, valued at
$381k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/19/2022 |
4
| Harris Theodore L (Chairman, President & CEO) has filed a Form 4 on BALCHEM CORP
Txns:
| Granted 130,000 options to buy
@ $0 |
|
08/16/2022 |
4
| van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns:
| Exercised 1,000 shares
@ $58.52, valued at
$58.5k
Sold 1,000 shares
@ $131.1207, valued at
$131.1k
|
|
08/09/2022 |
4
| van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns:
| Exercised 2,629 shares
@ $50.32, valued at
$132.3k
Sold 2,629 shares
@ $127.0079, valued at
$333.9k
|
|
08/05/2022 |
4
| van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns:
| Exercised 1,200 shares
@ $38.1, valued at
$45.7k
Exercised 1,000 shares
@ $58.52, valued at
$58.5k
Sold 2,200 shares
@ $126.0029, valued at
$277.2k
Sold 1,401 shares
@ $125.0165, valued at
$175.1k
Exercised 1,371 shares
@ $50.32, valued at
$69k
Sold 1,371 shares
@ $127.0026, valued at
$174.1k
|
|
02/16/2022 |
4
| Hyde James C (Sr. Vice President) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 348 shares
@ $139.38, valued at
$48.5k
|
|
02/16/2022 |
4
| Stach Mark A (General Counsel) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 302 shares
@ $139.38, valued at
$42.1k
|
|
02/16/2022 |
4
| Backus William A. (Chief Accounting Officer) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 470 shares
@ $139.38, valued at
$65.5k
|
|
02/16/2022 |
4
| Harris Theodore L (CEO & President) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 2,400 shares
@ $139.38, valued at
$334.5k
|
|
02/16/2022 |
4
| TELEVANTOS JOHN Y (Director) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 359 shares
@ $139.38, valued at
$50k
|
|
02/15/2022 |
4
| Hyde James C (Sr. Vice President) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 318 shares
@ $137.73, valued at
$43.8k
|
|
02/15/2022 |
4
| Stach Mark A (General Counsel) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 997 shares
@ $137.73, valued at
$137.3k
|
|
02/15/2022 |
4
| Backus William A. (Chief Accounting Officer) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 1,961 shares
@ $137.73, valued at
$270.1k
|
|
02/15/2022 |
4
| Bengtsson Carl Martin (CFO) has filed a Form 4 on BALCHEM CORP
Txns:
| Paid exercise price by delivering 664 shares
@ $137.73, valued at
$91.5k
|
|
|